期刊文献+

氯吡格雷和阿司匹林对心肌梗死的临床疗效比较 被引量:1

Clinical curative effect comparison of clopidogrel and aspirin for myocardial infarction
下载PDF
导出
摘要 目的:探讨阿司匹林+氯吡格雷和单用阿司匹林治疗心肌梗死的临床疗效。方法:将收治的100例心肌梗死患者按住院编号顺序随机分为对照组50例和治疗组50例,治疗组给予阿司匹林+氯吡格雷、单硝酸异山梨酯、阿托伐他汀等联合治疗,对照组给予阿司匹林、单硝酸异山梨酯、阿托伐他汀等联合治疗。结果:治疗组与对照组的疗效比较、临床心血管反应差异均具有统计学意义(P<0.05)。结论:阿司匹林+氯吡格雷联合治疗心肌梗死的临床疗效较单用阿司匹林组具有显著的优越性。 Objective :To discuss clinical curative effect comparison of aspirin + clopidogrel and aspirin alone for the therapy of myocardial infarction. Method: 100 cases of myocardial infarction patients were randomly divided into treatment group of 50 cases and control group of 50 cases according to the number order in hospital. The treatment group was given in combination therapy of aspirin + clopidogrel, isosorbide mononitrate, atorvastatin and so on; and the control group was given in combination therapy of aspirin, isosorbide mononitrate, atorvastatin and so on. Results:Its were statistically significant with the curative effect comparison of treatment group and control group, clinical cardiovascular reactions (P〈0.05), Conclusion: Clinical curative effect of in combination with aspirin and clopidogrel treatment group has significant advantages in comparision of aspirin group.
作者 陈培栋
出处 《北方药学》 2015年第5期30-31,共2页 Journal of North Pharmacy
关键词 氯吡格雷 阿司匹林 心肌梗死 临床疗效 Clopidogrel Aspirin Myocardial infarction Clinical curative effect
  • 相关文献

参考文献6

二级参考文献62

  • 1李洁,刘春风.阿司匹林抵抗[J].国外医学(脑血管疾病分册),2005,13(2):136-139. 被引量:20
  • 2李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 3刘岩,郝卫军,司全金,李小鹰.高龄老年应用氯吡格雷与阿司匹林抗血小板治疗的临床研究[J].中华老年心脑血管病杂志,2006,8(4):219-221. 被引量:22
  • 4Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿(译),David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志(中文版),2007,26(3):131-139. 被引量:59
  • 5第一届全国内科学术会议心血管病组.关于冠状动脉性心脏病命名及诊断标准的建议[J].中华心血管病杂志,1981,9(1):75-76.
  • 6W IVIOTT SD ,ANTMAN EM.Clop idogrel resistartee:a new chap ter in a fast2moving story [ J ].Circulation,2004,109 : 3064-3067.
  • 7NGUYEN TA,DIODAI JG,PHARAND C,et al.Resistance to clop idogrel:a review of the evidence [J].J Am Coll Cardiol, 2005,1945(8) : 1157-1164.
  • 8LAUWC, GURBEL PA ,WATKINS PB,et al.Contribution of hepatic cytochrome P4503A4 metabolic activity to the phenomenon of clop idogrel resistance [J ].Circulation, 2004,109 : 166-171.
  • 9NGUYEN PA,B LIDEN KP,HIATrBL,et al.Clop idogrel for coronary stenting response variability,drug resistance,and the effect of p retreatment p latelet reactivity [J].Cireulation,2003, 107 : 2908-2913.
  • 10LAU W,CARVILLED,BATESE.Clinical significance of the atorvastatin clopidogrel drug-drug interaction[J].Circulation, 2004,110(6): 66-67.

共引文献192

同被引文献13

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部